ES2940688T3 - Síntesis de halicondrinas - Google Patents

Síntesis de halicondrinas Download PDF

Info

Publication number
ES2940688T3
ES2940688T3 ES18746401T ES18746401T ES2940688T3 ES 2940688 T3 ES2940688 T3 ES 2940688T3 ES 18746401 T ES18746401 T ES 18746401T ES 18746401 T ES18746401 T ES 18746401T ES 2940688 T3 ES2940688 T3 ES 2940688T3
Authority
ES
Spain
Prior art keywords
optionally substituted
carbonate
compound
formula
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18746401T
Other languages
English (en)
Spanish (es)
Inventor
Takashi Fukuyama
Yoshito Kishi
Yanran Ai
Ning Ye
Qiaoyi Wang
Kenzo Yahata
Kentaro ISO
Santhosh Reddy Naini
Shuji Yamashita
Jihoon Lee
Isao Ohashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Harvard University
Original Assignee
Eisai R&D Management Co Ltd
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd, Harvard University filed Critical Eisai R&D Management Co Ltd
Application granted granted Critical
Publication of ES2940688T3 publication Critical patent/ES2940688T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)
ES18746401T 2017-07-06 2018-07-06 Síntesis de halicondrinas Active ES2940688T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762529310P 2017-07-06 2017-07-06
US201762529333P 2017-07-06 2017-07-06
PCT/US2018/041005 WO2019010363A1 (en) 2017-07-06 2018-07-06 HALICHONDRINES SYNTHESIS

Publications (1)

Publication Number Publication Date
ES2940688T3 true ES2940688T3 (es) 2023-05-10

Family

ID=63036376

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18746401T Active ES2940688T3 (es) 2017-07-06 2018-07-06 Síntesis de halicondrinas

Country Status (14)

Country Link
US (2) US11548898B2 (cg-RX-API-DMAC10.html)
EP (2) EP3649135B1 (cg-RX-API-DMAC10.html)
JP (2) JP7370313B2 (cg-RX-API-DMAC10.html)
KR (2) KR102438417B1 (cg-RX-API-DMAC10.html)
CN (2) CN111433211B (cg-RX-API-DMAC10.html)
AU (2) AU2018297305B2 (cg-RX-API-DMAC10.html)
BR (1) BR112020000141A2 (cg-RX-API-DMAC10.html)
CA (2) CA3211559A1 (cg-RX-API-DMAC10.html)
ES (1) ES2940688T3 (cg-RX-API-DMAC10.html)
HU (1) HUE061306T2 (cg-RX-API-DMAC10.html)
IL (3) IL271660B (cg-RX-API-DMAC10.html)
MX (1) MX2020000142A (cg-RX-API-DMAC10.html)
SG (1) SG11201912342QA (cg-RX-API-DMAC10.html)
WO (1) WO2019010363A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016003975A1 (en) 2014-06-30 2016-01-07 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
SI3606928T1 (sl) 2017-04-05 2023-02-28 President And Fellows Of Harvard College Makrociklična spojina in njene uporabe
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
CN111566113B (zh) * 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途
CN111484393A (zh) * 2019-01-28 2020-08-04 上海茂晟康慧科技有限公司 一种顺,顺-3,5-二甲基-1-环己醇的制备方法
CN117820275B (zh) * 2023-12-29 2026-06-02 上海科技大学 一种列净类药物及其中间体的催化合成方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191687A (ja) 1985-02-20 1986-08-26 Fujisawa Pharmaceut Co Ltd ハリコンドリンb
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
JP2818381B2 (ja) 1994-01-18 1998-10-30 帝人株式会社 7−チアプロスタグランジン類およびその製造法
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
CA2632433C (en) 1998-06-17 2012-02-07 Eisai R & D Management Co., Ltd. Methods for preparing macrocyclic analogs and intermediates for preparing same
JP2001305734A (ja) 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
KR101434673B1 (ko) 2004-06-03 2014-08-26 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 b 유사체의 제조를 위한 중간체
JP2008522623A (ja) 2004-12-09 2008-07-03 エーザイ株式会社 ハリコンドリンbアナログを使用した癌治療でのチューブリンアイソタイプのスクリーニング
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
CN201230323Y (zh) 2007-03-07 2009-04-29 美商内数位科技公司 用于产生和处理媒介接入控制协议数据单元的节点b
CN101918844A (zh) 2007-06-18 2010-12-15 米迪缪尼有限公司 表达epha2和erbb2的细胞的协同治疗
EP2578576B9 (en) 2007-10-03 2016-09-14 Eisai R&D Management Co., Ltd. Intermediates for the synthesis of halichondrin B analogs
CN101910180A (zh) 2007-11-16 2010-12-08 卫材R&D管理有限公司 用于软海绵素b类似物合成的新颖中间体和用于该中间体的新颖脱磺酰化反应
RU2517167C2 (ru) 2008-04-04 2014-05-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Аналоги галихондрина в
US8203010B2 (en) 2010-01-26 2012-06-19 Eisai R&D Management Co., Ltd. Compounds useful in the synthesis of halichondrin B analogs
WO2012096926A2 (en) 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
JP2015501818A (ja) 2011-12-16 2015-01-19 アルフォラ リサーチ インコーポレイテッドAlphora Research Inc. 3−((2s,5s)−4−メチレン−5−(3−オキソプロピル)テトラヒドロフラン−2−イル)プロパノール誘導体およびそれらの有用な中間体を調製する方法
IN2014MN01521A (cg-RX-API-DMAC10.html) 2011-12-29 2015-05-01 Alphora Res Inc
CN104334562A (zh) 2012-03-30 2015-02-04 阿方拉研究股份有限公司 用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体
US9650397B2 (en) 2013-05-15 2017-05-16 Alphora Research Inc. 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
WO2015000070A1 (en) 2013-07-03 2015-01-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
CA2929084C (en) 2013-11-04 2022-01-11 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin b
BR112016012237B1 (pt) 2013-12-06 2023-02-07 Eisai R&D Management Co., Ltd Métodos úteis na síntese de análogos de halicondrina b
WO2016003975A1 (en) 2014-06-30 2016-01-07 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10208058B2 (en) 2014-09-09 2019-02-19 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) * 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
MY199595A (en) 2016-03-02 2023-11-08 Eisai R&D Man Co Ltd Eribulin-based antibody-drug conjugates and methods of use
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
UA126029C2 (uk) 2017-02-20 2022-08-03 Поліфор Аґ Фармацевтичні комбінації для лікування раку
US9938288B1 (en) * 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
SI3606928T1 (sl) 2017-04-05 2023-02-28 President And Fellows Of Harvard College Makrociklična spojina in njene uporabe
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019009956A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College SUMMARY OF MEDIUM MEDIATED KETONE
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
CN111566113B (zh) 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途

Also Published As

Publication number Publication date
RU2020104842A (ru) 2021-08-06
HUE061306T2 (hu) 2023-06-28
CN111433211A (zh) 2020-07-17
MX2020000142A (es) 2020-07-22
IL307273A (en) 2023-11-01
US20230128195A1 (en) 2023-04-27
AU2018297305A1 (en) 2020-01-16
AU2018297305B2 (en) 2023-02-16
CA3069160A1 (en) 2019-01-10
US11548898B2 (en) 2023-01-10
IL307273B1 (en) 2024-11-01
JP2020536046A (ja) 2020-12-10
JP2023166381A (ja) 2023-11-21
IL295588B1 (en) 2023-11-01
IL271660A (en) 2020-02-27
US20210230177A1 (en) 2021-07-29
CN118515685A (zh) 2024-08-20
JP7370313B2 (ja) 2023-10-27
KR20200042464A (ko) 2020-04-23
CN111433211B (zh) 2024-05-07
EP4169924A2 (en) 2023-04-26
KR20220124279A (ko) 2022-09-13
IL295588B2 (en) 2024-03-01
EP3649135A1 (en) 2020-05-13
WO2019010363A8 (en) 2019-06-06
SG11201912342QA (en) 2020-01-30
CA3211559A1 (en) 2019-01-10
AU2023203013B2 (en) 2025-06-05
WO2019010363A1 (en) 2019-01-10
AU2023203013A1 (en) 2023-06-01
KR102438417B1 (ko) 2022-09-01
IL307273B2 (en) 2025-03-01
CA3069160C (en) 2023-10-17
IL295588A (en) 2022-10-01
EP4169924A3 (en) 2023-07-05
IL271660B (en) 2022-09-01
JP7764432B2 (ja) 2025-11-05
BR112020000141A2 (pt) 2020-07-14
EP3649135B1 (en) 2022-12-28

Similar Documents

Publication Publication Date Title
JP7764432B2 (ja) ハリコンドリンの合成
EP2550285B1 (en) Trioxacarcins and uses thereof
US11498892B2 (en) Fe/Cu-mediated ketone synthesis
US20200031843A1 (en) Chromium-mediated coupling and application to the synthesis of halichondrins
US10844073B2 (en) Palladium-mediated ketolization
WO2016003975A1 (en) Synthesis of halichondrin analogs and uses thereof
EP3664799A1 (en) Lincosamide antibiotics and uses thereof
WO2019009956A1 (en) SUMMARY OF MEDIUM MEDIATED KETONE
EP3710454B1 (en) Macrocyclic compounds and uses thereof
US20230135188A1 (en) Fe/cu-mediated ketone synthesis
WO2022019921A1 (en) Ketone synthesis and applications
RU2794176C2 (ru) Синтез галихондринов
JP7266267B2 (ja) Fe/cu媒介ケトン合成
WO2026025019A1 (en) Synthesis of macrobicyclic thiolincosamines
WO2024050554A2 (en) Synthesis of cotylenin and analogs thereof for the development of selective modulators of 14-3-3 protein-protein interaction
WO2026043875A1 (en) Synthesis of oxepanoprolines